| ²é¿´: 218 | »Ø¸´: 9 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
¸÷λ¸ßÊÖÇë½ø
|
|||
The active substance manufacturer's restricted ("closed" part of the EDMF should follow thestructure of Module 3.2.S of the CTD. A separate Quality Overall Summary for the information included in the active substance manufacturer's restricted ("closed" part shouldalso be provided, as part of the EDMF. ÕâÒ»¶ÎÊDz»ÊÇ˵Ã÷CTDÖÐÖÁÉÙÊÇÅ·ÖÞµÄÖÆ¼ÁÉ걨,³ýÁËÊÚȨÐÅÒÔÍâ,»¹ÊÇÐèÒªÔÁÏÒ©DMFµÄ¹«¿ª²¿·ÖÎļþºÍ·Ç¹«¿ª²¿·ÖÎļþÁ˰¡,²»ÊÇ˵²»Ó÷ǹ«¿ªµÄ²¿·ÖÂð, |
» ²ÂÄãϲ»¶
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
ÒѾÓÐ14È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ196È˻ظ´
Çë½Ìõ£°·ËõºÏ·´Ó¦
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸´óÁ¬Àí¹¤ÖÆÒ©¹¤³Ìר˶086002£¬±¾¿Æ211£¬×Ü·Ö342
ÒѾÓÐ0È˻ظ´
ÖÆÒ©¹¤³ÌרҵÕÐÊÕµ÷¼Á£¬ÒªÇó¹ý¹ú¼ÒÏß
ÒѾÓÐ0È˻ظ´
ÎåÒØ´óѧҩÎﻯѧÉúÎïѧÍŶÓ-ÀîÀ¼Çå¿ÎÌâ×éÕÐÊÕµ÷¼ÁѧÉú
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ1È˻ظ´
2Â¥2007-03-04 19:00:57
3Â¥2007-03-04 19:01:12
4Â¥2007-03-05 09:21:36
zhoudingcheng
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 6594.2
- Ìû×Ó: 334
- ÔÚÏß: 61.7Сʱ
- ³æºÅ: 117382
- ×¢²á: 2005-11-26
- רҵ: Óлú·ÖÎö

5Â¥2007-03-05 12:46:16
6Â¥2007-03-05 14:27:55
7Â¥2007-03-08 08:59:23
8Â¥2007-03-13 09:42:23














part of the EDMF should follow the
»Ø¸´´ËÂ¥